MiNK Therapeutics, Inc. INKT
12.18
(0.12)
(0.98%)
as of 25 Sep
- Market cap
- $62.8M
- P/E
- 0.0×
Follow INKT
Growth Flags
show if company had growth for consecutive years
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | — | 0.00 | — |
P/S ratio |
— | — | — | — | — | — | 0.00 | — |
P/FCF ratio |
— | — | — | — | — | — | 0.00 | — |
P/Operating CF |
— | — | — | — | — | — | (83.09) | — |
P/B ratio |
— | — | — | — | — | — | 0.00 | — |
Price to Tangible BV |
— | — | — | — | — | — | 0.00 | — |
EV/Sales |
— | — | — | — | — | — | 0.00 | — |
EV/EBITDA |
— | — | — | — | — | — | 0.00 | — |
EV/Operating CF |
— | — | — | — | — | — | (25.97) | — |
EV/FCF |
— | — | — | — | — | — | (25.47) | — |
Quick Ratio |
1.03 | 0.66 | 0.30 | 1.55 | 2.36 | 0.19 | 0.04 | — |
Current Ratio |
1.06 | 0.72 | 0.32 | 1.61 | 2.41 | 0.29 | 0.12 | — |
Net Debt/EBITDA |
1.07 | (0.03) | 0.15 | 0.64 | 1.38 | (2.82) | (1.19) | — |
Debt/Assets |
0.00% | 86.08% | 0.00% | 0.00% | 0.00% | 962.07% | 2,046.79% | 0.00% |
Debt/Equity |
0.00 | (0.25) | 0.00 | 0.00 | 0.00 | (0.81) | (0.74) | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.05 | — |
Operating CF/Net income |
0.47 | 0.89 | 0.70 | 0.67 | 0.42 | 0.51 | 0.63 | — |
Capex/Depreciation |
0.00 | 0.00 | (0.36) | (2.05) | (3.19) | (1.73) | (11.59) | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| 73.90% | 57.30% | 243.36% | (239.49%) | 200.76% | 36.00% | 52.77% | — | |
| (125.20%) | (209.96%) | (172.59%) | (90.71%) | (134.89%) | (553.84%) | (3,636.98%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(1,034.81%) | 870.51% | 327.84% | (318.50%) | (127.07%) | 167.98% | 389.56% | — |
Average Days of Receivables |
— | — | — | — | 0.00 | 0.00 | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2,850.07% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 555.10% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 31.84% | — |
Graham Net Nets |
— | — | — | — | — | — | (0.27) | — |
Graham Number |
— | — | — | — | — | — | 0.00 | — |
Earnings Yield |
— | — | — | — | — | — | (8.47%) | — |
Free Cash Flow Yield |
— | — | — | — | — | — | (4.51%) | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.29 | — |
Operating CF per Share |
(1.39) | (2.53) | (4.59) | (5.60) | (4.93) | (3.46) | (6.21) | — |
Capex per Share |
0.00 | 0.00 | (0.02) | (0.07) | (0.10) | (0.04) | (0.18) | — |
Free Cash Flow per Share |
(1.39) | (2.53) | (4.61) | (5.68) | (5.02) | (3.50) | (6.39) | — |
Cash per Share |
3.13 | 1.21 | 0.98 | 5.83 | 14.94 | 1.12 | 0.12 | — |
Shareholders Equity per Share |
(3.33) | (5.19) | (5.25) | (0.12) | 9.14 | (22.35) | (15.10) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
(3.33) | (5.19) | (5.25) | (0.12) | 9.14 | (22.35) | (15.10) | — |
Free Cash Flow |
(5.93) | (9.56) | (15.84) | (19.12) | (13.08) | (8.43) | (15.37) | — |
Working Capital |
0.82 | (1.97) | (7.80) | 7.72 | 23.17 | (10.13) | (6.50) | — |
Capital Expenditures |
— | — | (0.07) | (0.25) | (0.25) | (0.10) | (0.43) | — |
Net Current Asset Value |
(14.62) | (20.32) | (19.01) | (1.47) | 23.17 | (54.33) | (36.72) | — |
EV/EBIT |
— | — | — | — | — | — | 0.00 | — |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.62 | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (3,451.60%) | — |
Price to Operating Income |
— | — | — | — | — | — | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.46 | 0.29 | 0.21 | 0.11 | 0.13 | 0.12 | 0.09 | — |
Cash ROIC |
728.16% | 102.02% | 113.81% | (103.64%) | (21.44%) | 119.53% | 165.88% | — |
Accounts Receivable Turnover |
— | — | — | — | 0.00 | 0.00 | 1.77 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | — | — |
Average Receivables |
— | — | — | — | 0.14 | 0.39 | 0.39 | — |
Average Payables |
3.08 | 3.32 | 4.87 | 4.41 | 3.07 | 2.80 | 2.80 | — |
Average Assets |
9.98 | 5.14 | 13.01 | 30.86 | 22.40 | 2.93 | 0.65 | — |
Average Common Equity |
(16.91) | (18.82) | (9.23) | 11.69 | (15.05) | (45.10) | (45.10) | — |
Columns are period end dates